Viewing Study NCT03224104


Ignite Creation Date: 2025-12-24 @ 7:54 PM
Ignite Modification Date: 2026-01-04 @ 5:50 PM
Study NCT ID: NCT03224104
Status: COMPLETED
Last Update Posted: 2025-11-26
First Post: 2017-07-06
Is Gene Therapy: True
Has Adverse Events: True

Brief Title: Multi-kinase Inhibitor TG02 (TG02) in Elderly Newly Diagnosed or Adult Relapsed Patients With Anaplastic Astrocytoma or Glioblastoma.
Sponsor: European Organisation for Research and Treatment of Cancer - EORTC
Organization:

Organization Data

Organization:
Class: NETWORK
Study ID: EORTC-1608-BTG
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: NETWORK
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators

Collaborators

Name Class View
None INDUSTRY View